Back
Arcutis Biotherapeutics Stock Predictions
Sponsored
ARQT
Sponsored
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.03
Seasonality Move:
-20.86%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!Arcutis Biotherapeutics Stock Forecast
- Over the next 52 weeks, Arcutis Biotherapeutics has on average historically fallen by 8.8% based on the past 4 years of stock performance.
- Arcutis Biotherapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Arcutis Biotherapeutics Stock Undervalued?
The current Arcutis Biotherapeutics [ARQT] share price is $10.02. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal. - ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Arcutis Biotherapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Arcutis Biotherapeutics has on average historically fallen by 8.8% based on the past 4 years of stock performance.
Arcutis Biotherapeutics Stock Rating
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics overpriced?
- Arcutis Biotherapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Arcutis Biotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcutis.com
52-Week Data
52-Week High:
13.17
52-Week Low:
1.76
Prediction Charts
Market Cap:
1.17B
Price in USD:
10.02
Volume:
1.62M
Beta:
1.19
Technical Analysis
SMA50:
9.80
SMA100:
9.48
SMA200:
8.60
52-Wk Change:
122.67%
Stock Predictions
-
Is Arcutis Biotherapeutics stock public?
Yes, Arcutis Biotherapeutics is a publicly traded company. -
What is the Arcutis Biotherapeutics stock quote today?
The Arcutis Biotherapeutics stock price is 10.02 USD today. -
How to buy Arcutis Biotherapeutics stock online?
You can buy Arcutis Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-17 | 10.23 | 10.37 | 10.80 | 10.23 |
Sep-18 | 10.26 | 10.39 | 10.71 | 9.90 |
Sep-19 | 10.69 | 10.14 | 11.18 | 10.04 |
Sep-20 | 10.17 | 10.15 | 10.31 | 9.78 |
Sep-23 | 10.12 | 9.63 | 10.25 | 9.47 |
Sep-24 | 9.61 | 9.67 | 10.04 | 9.40 |
Sep-25 | 9.68 | 9.10 | 9.79 | 9.02 |
Sep-26 | 9.12 | 9.15 | 9.68 | 9.11 |
Sep-27 | 9.25 | 9.36 | 9.37 | 9.04 |
Sep-30 | 9.32 | 9.30 | 9.74 | 9.14 |
Oct-1 | 9.27 | 9.56 | 9.62 | 9.21 |
Oct-2 | 9.51 | 10.23 | 10.34 | 9.43 |
Oct-3 | 10.14 | 10.17 | 10.67 | 10.06 |
Oct-4 | 10.20 | 10.02 | 10.44 | 9.83 |
Arcutis Biotherapeutics Earnings
Arcutis Biotherapeutics Earnings Report: Per Share Arcutis Biotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcutis Biotherapeutics Forecast Revenue Growth
Arcutis Biotherapeutics Stock Analysis: Historical quarterly revenues per share for Arcutis Biotherapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.45 per share, and an increase next year of $0.38 per share.
* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.